Market

Key Challenges and Innovations in Science and Pharma Sectors
Research & Development Key Challenges and Innovations in Science and Pharma Sectors

The current landscape of the scientific and pharmaceutical industries presents a fascinating blend of unprecedented advancements and complex challenges that continue to redefine the sector. As these industries evolve, they encounter critical opportunities for growth alongside significant hurdles

CROs Shift to Alternative Methods Following FDA Animal Testing Phase-Out
Research & Development CROs Shift to Alternative Methods Following FDA Animal Testing Phase-Out

Chinese contract research organization GemPharmatech has expanded its presence in the United States with a new facility in San Diego, announced on April 17. The facility is designed for laboratories and housing genetically engineered mouse models, aimed at enhancing their capabilities in offering

What Will Drive the Future of Nitinol Medical Devices?
Management & Regulatory What Will Drive the Future of Nitinol Medical Devices?

The realm of medical devices is on a transformative path, markedly influenced by the integration of advanced materials like Nitinol. Known for its remarkable superelasticity, shape memory effect, and superior damping characteristics, Nitinol stands as a cornerstone in the development of innovative

Recce Pharmaceuticals Secures $15.8M to Advance Phase 3 Trials
Research & Development Recce Pharmaceuticals Secures $15.8M to Advance Phase 3 Trials

Recce Pharmaceuticals, a Sydney-based biotechnology company, has successfully raised A$15.8 million to advance its groundbreaking anti-infective drugs into Phase 3 trials. This funding was obtained through a combination of private placement and an entitlement offer. Recce's synthetic

Navigating Medtech Challenges: Regulatory, Reshoring, and Tech Gaps
Management & Regulatory Navigating Medtech Challenges: Regulatory, Reshoring, and Tech Gaps

The medical and life sciences manufacturing sector is experiencing rapid transformations, bringing forth a plethora of challenges and opportunities for industry professionals. Ascential's "2025 State of Medical & Life Sciences Manufacturing" report delves into key areas such as

Is Leadership Reshaping the Future of Biopharma CDMOs?
Biotech & Bioprocessing Is Leadership Reshaping the Future of Biopharma CDMOs?

The biopharmaceutical sector has witnessed significant changes in leadership roles within major Contract Development and Manufacturing Organizations (CDMOs), driving strategic growth and development. The appointment of seasoned leaders plays a crucial role in strengthening the research,

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later